O M Lemine

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Atomic Force Microscopy

Top Venues

Nanomaterials (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kheireddine El-Boubbou, O M Lemine, Saja Algessair, Nawal Madkhali, Basma Al-Najar, Enas AlMatri, Rizwan Ali, Mohamed Henini
Preparation and characterization of various PVPylated divalent metal-doped ferrite nanoparticles for magnetic hyperthermia. RSC advances 14 (22) (2024)
Kheireddine El-Boubbou, O M Lemine, Saja Algessair, Nawal Madkhali, Basma Al-Najar, Enas AlMatri, Rizwan Ali, Mohamed Henini
Preparation and characterization of various PVPylated divalent metal-doped ferrite nanoparticles for magnetic hyperthermia. RSC advances 14 (22) (2024)
O M Lemine, Saja Algessair, Nawal Madkhali, Basma Al-Najar, Kheireddine El-Boubbou
Assessing the Heat Generation and Self-Heating Mechanism of Superparamagnetic Fe 3 O 4 Nanoparticles for Magnetic Hyperthermia Application: The Effects of Concentration, Frequency, and Magnetic Field. Nanomaterials (Basel, Switzerland) 13 (3) (2023)
O M Lemine, Saja Algessair, Nawal Madkhali, Basma Al-Najar, Kheireddine El-Boubbou
Assessing the Heat Generation and Self-Heating Mechanism of Superparamagnetic Fe 3 O 4 Nanoparticles for Magnetic Hyperthermia Application: The Effects of Concentration, Frequency, and Magnetic Field. Nanomaterials (Basel, Switzerland) 13 (3) (2023)
O M Lemine, Saja Algessair, Nawal Madkhali, Basma Al-Najar, Kheireddine El-Boubbou
Assessing the Heat Generation and Self-Heating Mechanism of Superparamagnetic Fe 3 O 4 Nanoparticles for Magnetic Hyperthermia Application: The Effects of Concentration, Frequency, and Magnetic Field. Nanomaterials (Basel, Switzerland) 13 (3) (2023)
Kheireddine El-Boubbou, Rizwan Ali, Sulaiman Al-Humaid, Alshaimaa Alhallaj, O M Lemine, Mohamed Boudjelal, Abdulmohsen Alkushi
Iron Oxide Mesoporous Magnetic Nanostructures with High Surface Area for Enhanced and Selective Drug Delivery to Metastatic Cancer Cells. Pharmaceutics 13 (4) (2021)